$55.38
-0.65-1.16%
Last update: Nov 9, 9:42 AM
BioMarin Pharmaceutical Inc
BMRNNASDAQ
The average analyst price target for BioMarin Pharmaceutical is $88.64, 60.1% above the current price. Of 28 analysts, 20 rate it Buy and 8 Hold. Targets range from $60 to $126. The latest change came on Nov 4, 2026, when JP Morgan lowered its price target on BioMarin Pharmaceutical from $87 to $86 and kept an Overweight rating.
Price Target Range — 10 Quarters
Analyst Consensus — 28 Analysts
Rating Trend — Last 9 Months
